Humana Inc: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Jul 29, 2015 and accepted by EDGAR at Jul 29, 2015, 09:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $13.73bn | us-gaap:Revenues |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $27.57bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2015-04-01 to 2015-06-30 | $1.82bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2015-01-01 to 2015-06-30 | $3.76bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-04-01 to 2015-06-30 | $573.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-01-01 to 2015-06-30 | $1.36bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $47.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $93.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-04-01 to 2015-06-30 | $362.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2015-01-01 to 2015-06-30 | $676.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-04-01 to 2015-06-30 | $431.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-01-01 to 2015-06-30 | $861.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | $2.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2015-01-01 to 2015-06-30 | $5.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | $2.88 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-01-01 to 2015-06-30 | $5.74 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 151,148,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-01-01 to 2015-06-30 | 151,748,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | −$501.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2015-01-01 to 2015-06-30 | $259.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2015-01-01 to 2015-06-30 | $86.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2015-01-01 to 2015-06-30 | $371.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-06-30 | $2.25bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $16.98bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $25.38bn | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $8.97bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $15.30bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-06-30 | $3.82bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2015-06-30 | $300.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2015-06-30 | $10.08bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-06-30 | 148,143,674 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-15-000075. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.